MATTHEW PAUL EDELSON's most recent trade in Ajanta Pharma Ltd. was a Disposal of 113 Equity Shares done at an average price of Rs. 2127.7 . Disclosure was reported to the exchange on Nov. 9, 2021 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for MATTHEW PAUL EDELSON in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ajanta Pharma | Matthew Paul Edelson | Designated Person | Disposal | 09 Nov 2021 | 113 | 1,000 (0%) | 0.00% | 2127.7 | 240,433 | 08 Nov 2021 08 Nov 2021 |
Insider Trading | Equity Shares | Market Sale |
| Ajanta Pharma | Matthew Paul Edelson | Designated Person | Disposal | 09 Nov 2021 | 287 | 1,113 (0%) | 0.00% | 2140.9 | 614,448 | 04 Nov 2021 04 Nov 2021 |
Insider Trading | Equity Shares | Market Sale |
| Ajanta Pharma | Matthew Paul Edelson | Designated Person | Disposal | 09 Nov 2021 | 100 | 1,400 (0%) | 0.00% | 2124.5 | 212,454 | 03 Nov 2021 03 Nov 2021 |
Insider Trading | Equity Shares | Market Sale |
| Ajanta Pharma | MATTHEW PAUL EDELSON | Designated Person | Disposal | 09 Jun 2021 | 100 | 500 (0%) | 0.00% | 1902.6 | 190,262 | 07 Jun 2021 07 Jun 2021 |
Insider Trading | Equity Shares | Market Sale |
| Ajanta Pharma | MATTHEW PAUL EDELSON | Designated Person | Disposal | 09 Jun 2021 | 900 | 600 (0%) | 0.00% | 1890.0 | 1,700,975 | 04 Jun 2021 04 Jun 2021 |
Insider Trading | Equity Shares | Market Sale |